Mangoceuticals(US:MGRX) Newsfilter·2025-02-06 12:00Core Viewpoint - Mangoceuticals, Inc. is making significant advancements in its research on respiratory illness prevention technologies, particularly focusing on H1N1 and H5N1 viruses, showcasing the potential of its proprietary formulations [1][2][3][4]. Research Progress - The company has progressed to the next stage of its H1N1 efficacy study, which has shown promising preliminary results, including a significant reduction in viral load [2][3]. - A new cohort for evaluating the technology against the H5N1 virus is being structured to run concurrently with the ongoing H1N1 study [2][4]. Technology and Innovation - The studies utilize Mangoceuticals' proprietary formulation of advanced polyphenol and zinc chemistry, indicating a strong foundation for further exploration and applications [3]. - The company's commitment to addressing global health concerns through innovative solutions is emphasized by its ongoing research efforts [4]. Market Focus - Mangoceuticals is dedicated to developing a variety of men's health and wellness products and services, particularly in the telemedicine sector, which includes areas such as erectile dysfunction, hair growth, hormone replacement therapies, and weight management [5].